David Fellows
Chief Executive Officer
David has more than 40 years of experience in various leadership roles within the ophthalmic pharmaceutical industry and is currently the Board Chairman of Oxular and a Board member of the Glaucoma Foundation. He was previously CEO of Nightstar Therapeutics, a private biopharmaceutical company specialising in developing ocular gene therapies for patients with inherited retinal dystrophies with David leading the company through a successful NASDAQ listing and M&A transaction. He was previously Vice President of Johnson & Johnson’s Vision Care Franchise, and, prior to that, held several roles at Allergan for 25 years, including Regional President. Mr. Fellows holds a B.A. in Psychology from Butler University.